Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulation of fish chronic toxicity using the Las Vegas algorithm and the vector of ideality of correlation.

Environmental toxicology and chemistry·2026
Same author

Molecular deep learning at the edge of chemical space.

Nature machine intelligence·2026
Same author

QSAR Models for Repeated Dose Toxicity in Rats Using the CORAL Software.

Toxics·2026
Same author

Perspective on applicability of data-driven machine learning computational new approach methodologies for hazard identification in chemicals risk assessment.

Journal of cheminformatics·2026
Same author

Machine learning for biomolecular modeling.

The Journal of chemical physics·2026
Same author

Advancing the implementation of artificial intelligence in regulatory frameworks for chemical safety assessment by defining robust readiness criteria.

Frontiers in artificial intelligence·2026

Related Experiment Video

Updated: Jun 3, 2026

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes
09:17

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes

Published on: August 9, 2022

Beyond Molecular Structures: Investigating Demographic Factors in Drug-Induced Cardiotoxicity Prediction Models.

Mateusz Iwan1,2, Alessandra Roncaglioni2, Francesca Grisoni1

  • 1Department of Biomedical Engineering, Eindhoven University of Technology, Institute for Complex Molecular Systems (ICMS), P.O. Box 513, Eindhoven 5600 MB, The Netherlands.

Journal of Chemical Information and Modeling
|June 2, 2026
PubMed
Summary

Predicting drug-induced cardiotoxicity is difficult. Machine learning models using demographic data from pharmacovigilance databases did not improve predictions, highlighting limitations for personalized drug safety.

More Related Videos

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
10:30

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

Related Experiment Videos

Last Updated: Jun 3, 2026

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes
09:17

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes

Published on: August 9, 2022

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
10:30

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

Area of Science:

  • Pharmacology
  • Toxicology
  • Computational Biology

Background:

  • Drug-induced cardiotoxicity is a major safety concern, causing trial failures and drug withdrawals.
  • Existing models struggle to incorporate demographic factors (sex, age, body mass) for personalized risk prediction.

Purpose of the Study:

  • To develop and evaluate the CARBIDE (CARdiotoxicity Based on Integrated Demographic Evidence) framework.
  • To assess if structure-demographic interactions can be learned from spontaneous pharmacovigilance data for cardiotoxicity prediction.

Main Methods:

  • Created 27 dataset variants from the FAERS database.
  • Systematically evaluated filtering criteria, cardiotoxicity definitions, and statistical methods.
  • Conducted ablation studies to assess the impact of demographic features.

Main Results:

  • Machine learning models failed to learn meaningful structure-demographic relationships.
  • Demographic features provided little additional predictive value beyond structural information.
  • Models primarily learned population-level statistics or relied solely on chemical structure.

Conclusions:

  • Current pharmacovigilance data has fundamental limitations for demographic-aware toxicity prediction.
  • CARBIDE provides insights into these limitations, guiding future personalized cardiotoxicity prediction efforts.